US HIFU, LLC

US HIFU, LLC (US HIFU) is engaged in the distribution of medical equipments. It markets image-guided acoustic ablation devices developed using ultrasound energy for the detection of cancer and soft tissue diseases. The company distributes Sonablate 500 which is developed for prostate disease therapy using High Intensity Focused Ultrasound (HIFU). Its uses intersecting, precision-focused ultrasound waves and raises the temperature of the target tissue to more than 80 to 90 degrees Celsius for destroying the tissue. Sonablate 500 currently undergoing phase III clinical trial in US. It distributes across Europe, Canada, China, Australia, Japan, Costa Rica, South Africa and the Caribbean. US HIFU is headquartered at Charlotte in North Carolina, the US.

Recently, the company entered into a partnership with Riverside Research Institute (RRI) for the development and testing of an ultrasonic method of prostate imaging and treatment.

Street: 
801 E. Morehead St.
City: 
Charlotte
Postcode: 
28202
Federal State : 
United States
WebSite: 
www.ushifu.com

Company Index Score

Current Index Score Historical Index Score
  • US HIFU, LLC currently scores 50 % in the index.
  • US HIFU, LLC is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • US HIFU, LLC is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets